What stood out: CagriSema achieved 23.0% weight loss at 84 weeks (efficacy estimand) Tirzepatide achieved 25.5% On the treatment-regimen estimand, weight loss was 20.2% vs 23.6% Primary endpoint not met: CagriSema did not demonstrate non-inferiority vs tirzepatide on weight loss at 84 weeks Why this matters This is a reminder that in obesity pharmacotherapy, very effective and best-in-class are not the same conversation

Some of the documented effects: DNA repair properties, including the ability to reset gene expression patterns associated with aging Clearance of accumulated damaged proteins linked to cellular senescence Promotion of nerve fiber regeneration and increased production of neurotrophic factors Anti-cancer mechanisms, including prevention of metastasis in colon cancer Reversal of fibroblast dysfunction associated with COPD Reduction of anxiety and aggression via neurological pathways Pain-relieving effects through decreased expression of pain-related genes Stimulation of wound healing, even in tissue compromised by prior steroid use Not sure which peptide protocol fits your goals
But does it directly influence our weight
Unlike approved agents such as semaglutide (Wegovy) or tirzepatide (Zepbound), retatrutide has not yet received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for use in the United Kingdom
BPC-157 Price range: $65.00 through $125.00 Ships same day on orders placed by 3pm ET
The difference in purity, dosing accuracy, and safety oversight is not a minor distinction